These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment of "locally advanced" well-differentiated thyroid carcinomas. Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382 [TBL] [Abstract][Full Text] [Related]
24. Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma. Zuniga S; Sanabria A Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1087-91. PubMed ID: 19917919 [TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of level V occult metastasis of papillary thyroid carcinoma]. Liu J; Tang PZ; Xu ZG Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):313-5. PubMed ID: 20510088 [TBL] [Abstract][Full Text] [Related]
27. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts. Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0. Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700 [TBL] [Abstract][Full Text] [Related]
29. High recurrent rate of multicentric papillary thyroid carcinoma. Lin JD; Chao TC; Hsueh C; Kuo SF Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244 [TBL] [Abstract][Full Text] [Related]
30. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Roh JL; Kim JM; Park CI Ann Surg Oncol; 2008 Sep; 15(9):2482-6. PubMed ID: 18612697 [TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of young adult thyroid papillary cancer patients with bilateral cervical metastases]. Zhang L; Guo Z; Wang YL; Ji QH Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):467-9. PubMed ID: 17686304 [TBL] [Abstract][Full Text] [Related]
32. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Michels JJ; Jacques M; Henry-Amar M; Bardet S Hum Pathol; 2007 Feb; 38(2):212-9. PubMed ID: 17097131 [TBL] [Abstract][Full Text] [Related]
34. Multicentric prospective study on the prevalence of sublevel IIb metastases in head and neck cancer. Villaret AB; Piazza C; Peretti G; Calabrese L; Ansarin M; Chiesa F; Pellini R; Spriano G; Nicolai P Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):897-903. PubMed ID: 17875856 [TBL] [Abstract][Full Text] [Related]
35. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Leung AK; Chow SM; Law SC Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951 [TBL] [Abstract][Full Text] [Related]
36. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma. Lee SH; Lee SS; Jin SM; Kim JH; Rho YS Laryngoscope; 2008 Apr; 118(4):659-62. PubMed ID: 18176339 [TBL] [Abstract][Full Text] [Related]
37. [Our experience with papillary microcarcinoma of the thyroid]. Garrel R; Cartier C; Marvaso V; Corpelet D; Makeieff M; Crampette L; Guerrier B Rev Laryngol Otol Rhinol (Bord); 2002; 123(4):239-42. PubMed ID: 12723489 [TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors of papillary carcinomas of the thyroid gland--retrospective multivariate analysis of 227 patients with median follow-up 130 months]. Kure Y Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1420-6. PubMed ID: 1448049 [TBL] [Abstract][Full Text] [Related]
39. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype. Falvo L; D'Ercole C; Sorrenti S; D'Andrea V; Catania A; Berni A; Grilli P; De Antoni E Eur J Surg Suppl; 2003 Jul; (588):28-32. PubMed ID: 15200040 [TBL] [Abstract][Full Text] [Related]
40. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]